Literature DB >> 23659209

Discovery of potent, selective chymase inhibitors via fragment linking strategies.

Steven J Taylor1, Anil K Padyana, Asitha Abeywardane, Shuang Liang, Ming-Hong Hao, Stéphane De Lombaert, John Proudfoot, Bennett S Farmer, Xiang Li, Brandon Collins, Leslie Martin, Daniel R Albaugh, Melissa Hill-Drzewi, Steven S Pullen, Hidenori Takahashi.   

Abstract

Chymase plays an important and diverse role in the homeostasis of a number of cardiovascular processes. Herein, we describe the identification of potent, selective chymase inhibitors, developed using fragment-based, structure-guided linking and optimization techniques. High-concentration biophysical screening methods followed by high-throughput crystallography identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not observed in chymase inhibitors. X-ray crystallographic structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over cathepsin G and that mitigated a number of liabilities associated with poor physicochemical properties of the series it was derived from.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23659209     DOI: 10.1021/jm400138z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

Review 2.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

3.  Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins.

Authors:  Mihaela D Smilova; Peter R Curran; Chris J Radoux; Frank von Delft; Jason C Cole; Anthony R Bradley; Brian D Marsden
Journal:  J Chem Inf Model       Date:  2022-01-12       Impact factor: 4.956

4.  Indole Inhibitors of MMP-13 for Arthritic Disorders.

Authors:  Steven J Taylor; Asitha Abeywardane; Shuang Liang; Zhaoming Xiong; John R Proudfoot; Bennett Sandy Farmer; Donghong A Gao; Alexander Heim-Riether; Lana Louise Smith-Keenan; Ingo Muegge; Yang Yu; Qiang Zhang; Donald Souza; Mark Panzenbeck; Daniel Goldberg; Melissa Hill-Drzewi; Mariana Margarit; Brandon Collins; John Xiang Li; Ljiljana Zuvela-Jelaska; Jun Li; Neil A Farrow
Journal:  ACS Omega       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.